Latest Methotrexate Stories
Potential U.S. Commercialization Targeted for 2014 CHICAGO, Jan.
In the U.S., there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses according to estimates from the American College of Rheumatology (ACR).
Reportbuyer.com just published a new market research report:
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
- To give a box on the ear to.